Talens, Francien <br/><br/>
Therapeutic targeting and patient selection for cancers with homologous recombination defects.  [electronic resource] 

 -  Expert opinion on drug discovery  Jun 2017 
 - 565-581 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1746-045X 
<br/><br/><label>Standard No.: </label>10.1080/17460441.2017.1322061  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>BRCA1 Protein--genetics<br/>BRCA2 Protein--genetics<br/>Breast Neoplasms--drug therapy<br/>DNA Breaks, Double-Stranded<br/>Drug Design<br/>Female<br/>Genetic Predisposition to Disease<br/>Humans<br/>Molecular Targeted Therapy<br/>Mutation<br/>Ovarian Neoplasms--drug therapy<br/>Patient Selection<br/>Poly(ADP-ribose) Polymerase Inhibitors--pharmacology<br/>Recombinational DNA Repair--genetics